BackgroundTo explore the clinical value of preoperative transrectal three-dimensional ultrasound in diagnosing the internal opening and classifying complex anal fistulas, and to evaluate its impact on surgical efficacy.MethodsA total of 42 patients with complex anal fistulas were divided into an observation group and a control group. The control group underwent conventional transrectal ultrasound examination, while the observation group underwent three-dimensional transrectal ultrasound examination. Perioperative data were recorded and compared between the two groups.ResultsThe observation group showed significantly higher diagnostic accuracy (p = 0.014) and a higher cure rate (66.67% vs. 42.86%) than the control group. Anal sphincter function improved postoperatively in both groups, with the observation group achieving superior outcomes at 6 months. The observation group also demonstrated lower Wexner incontinence scores (p = 0.015), shorter hospitalization and wound healing times, and higher SF-36 scores in bodily pain, general health, and health transition domains. However, postoperative complication rates and 6-month recurrence rates were similar between the two groups.ConclusionPreoperative transrectal three-dimensional ultrasound can accurately identify the internal opening and fistula tract of complex anal fistulas, which is beneficial for improving treatment efficacy.
{"title":"Preoperative transrectal three-dimensional ultrasound improves complex anal fistula diagnosis and surgical outcomes.","authors":"Shuai Xu, Yue Shen, E Gong, Zixuan Liu, Qi Jin, Nanxin Zheng","doi":"10.1177/03000605261430476","DOIUrl":"https://doi.org/10.1177/03000605261430476","url":null,"abstract":"<p><p>BackgroundTo explore the clinical value of preoperative transrectal three-dimensional ultrasound in diagnosing the internal opening and classifying complex anal fistulas, and to evaluate its impact on surgical efficacy.MethodsA total of 42 patients with complex anal fistulas were divided into an observation group and a control group. The control group underwent conventional transrectal ultrasound examination, while the observation group underwent three-dimensional transrectal ultrasound examination. Perioperative data were recorded and compared between the two groups.ResultsThe observation group showed significantly higher diagnostic accuracy (p<i> = </i>0.014) and a higher cure rate (66.67% vs. 42.86%) than the control group. Anal sphincter function improved postoperatively in both groups, with the observation group achieving superior outcomes at 6 months. The observation group also demonstrated lower Wexner incontinence scores (p<i> = </i>0.015), shorter hospitalization and wound healing times, and higher SF-36 scores in bodily pain, general health, and health transition domains. However, postoperative complication rates and 6-month recurrence rates were similar between the two groups.ConclusionPreoperative transrectal three-dimensional ultrasound can accurately identify the internal opening and fistula tract of complex anal fistulas, which is beneficial for improving treatment efficacy.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261430476"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147504122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-08DOI: 10.1177/03000605261421738
Xiao-Xue Li, Feng-Shun Wang, Hao Wang, Li-Jun Gao, Kai Liu
BackgroundAbdominal aortic calcification, a subclinical marker of atherosclerosis, shares pathophysiological pathways with musculoskeletal decline. Although grip strength is an established predictor of cardiovascular outcomes, its association with abdominal aortic calcification in sex-specific analysis remains underexplored.MethodsThis cross-sectional study analyzed data from 1683 adults in National Health and Nutrition Examination Survey 2013-2014. Abdominal aortic calcification was quantified via dual-energy X-ray absorptiometry using Kauppila scores (L1-L4), with abdominal aortic calcification defined as a score >0. Muscle strength was evaluated using a standardized grip strength measurement (Takei dynamometer). Multivariable logistic regression, adjusted for demographic, metabolic, and lifestyle factors, were used to examine sex-specific associations. Restricted cubic splines were applied to evaluate dose-response relationships.ResultsAmong 903 men (mean age, 58.3 ± 12.0 years) and 780 women (mean age, 57.2 ± 11.9 years), each 1-kg increase in grip strength was associated with a 1.8% reduction in abdominal aortic calcification risk (odds ratio, 0.982; 95% confidence interval: 0.971-0.993) in men and a 2.6% reduction (odds ratio, 0.974; 95% confidence interval: 0.955-0.993) in women. Dose-response curves demonstrated linear inverse relationships (p < 0.05). Subgroup analyses confirmed consistency of this association across age, body mass index, hypertension, and diabetes status (all p for interaction > 0.05).ConclusionMuscle strength exhibits an independent, dose-dependent inverse association with the prevalence of abdominal aortic calcification, which persists across demographic subgroups. These findings support the use of grip strength as a practical biomarker for abdominal aortic calcification risk stratification and highlight musculoskeletal health as a potential target for interventions to prevent vascular calcification.
{"title":"Association of muscle strength with abdominal aortic calcification.","authors":"Xiao-Xue Li, Feng-Shun Wang, Hao Wang, Li-Jun Gao, Kai Liu","doi":"10.1177/03000605261421738","DOIUrl":"10.1177/03000605261421738","url":null,"abstract":"<p><p>BackgroundAbdominal aortic calcification, a subclinical marker of atherosclerosis, shares pathophysiological pathways with musculoskeletal decline. Although grip strength is an established predictor of cardiovascular outcomes, its association with abdominal aortic calcification in sex-specific analysis remains underexplored.MethodsThis cross-sectional study analyzed data from 1683 adults in National Health and Nutrition Examination Survey 2013-2014. Abdominal aortic calcification was quantified via dual-energy X-ray absorptiometry using Kauppila scores (L1-L4), with abdominal aortic calcification defined as a score >0. Muscle strength was evaluated using a standardized grip strength measurement (Takei dynamometer). Multivariable logistic regression, adjusted for demographic, metabolic, and lifestyle factors, were used to examine sex-specific associations. Restricted cubic splines were applied to evaluate dose-response relationships.ResultsAmong 903 men (mean age, 58.3 ± 12.0 years) and 780 women (mean age, 57.2 ± 11.9 years), each 1-kg increase in grip strength was associated with a 1.8% reduction in abdominal aortic calcification risk (odds ratio, 0.982; 95% confidence interval: 0.971-0.993) in men and a 2.6% reduction (odds ratio, 0.974; 95% confidence interval: 0.955-0.993) in women. Dose-response curves demonstrated linear inverse relationships (<i>p</i> < 0.05). Subgroup analyses confirmed consistency of this association across age, body mass index, hypertension, and diabetes status (all <i>p</i> for interaction > 0.05).ConclusionMuscle strength exhibits an independent, dose-dependent inverse association with the prevalence of abdominal aortic calcification, which persists across demographic subgroups. These findings support the use of grip strength as a practical biomarker for abdominal aortic calcification risk stratification and highlight musculoskeletal health as a potential target for interventions to prevent vascular calcification.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261421738"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12968405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147377728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-05DOI: 10.1177/03000605261429174
{"title":"Retraction: Evaluation of physician experience in achieving non-perfused volume ratio of high-intensity focused ultrasound ablation for uterine fibroids: a multicentre study.","authors":"","doi":"10.1177/03000605261429174","DOIUrl":"10.1177/03000605261429174","url":null,"abstract":"","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261429174"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12966504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147365412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveDepressive symptoms are a common disorder influenced by various factors, including genetic, environmental, and psychosocial aspects. This study aimed to explore the association between depressive symptoms and the number of close friends.MethodsThis cross-sectional study employed data from the 2005-2008 National Health and Nutrition Examination Survey. Weighted logistic regression was used to analyze the relationship between the number of close friends and depressive symptoms, and restricted cubic spline plots were constructed. Subgroup and sensitivity analyses were also performed.ResultsThis study included 5564 participants. After grouping participants based on the number of close friends into tertiles, a negative association was found between the number of close friends and depressive symptoms. After adjustment, the group with a higher number of close friends exhibited a 48% lower risk of depressive symptoms. An approximately L-shaped relationship was observed (nonlinear P = 0.001). Depressive symptoms decreased with an increasing number of close friends up to 10, beyond which the association plateaued.ConclusionAn approximately L-shaped relationship exists between the number of close friends and depressive symptoms. When the number of close friends was ≤10, a higher number of close friends was associated with a lower level of depressive symptoms.
{"title":"L-shaped association between depressive symptoms and the number of close friends: A cross-sectional study.","authors":"Quan Yuan, Jingshan Bai, Wenqiang Li, Ying Yang, Zhiping Deng, Qian Huang","doi":"10.1177/03000605261429192","DOIUrl":"10.1177/03000605261429192","url":null,"abstract":"<p><p>ObjectiveDepressive symptoms are a common disorder influenced by various factors, including genetic, environmental, and psychosocial aspects. This study aimed to explore the association between depressive symptoms and the number of close friends.MethodsThis cross-sectional study employed data from the 2005-2008 National Health and Nutrition Examination Survey. Weighted logistic regression was used to analyze the relationship between the number of close friends and depressive symptoms, and restricted cubic spline plots were constructed. Subgroup and sensitivity analyses were also performed.ResultsThis study included 5564 participants. After grouping participants based on the number of close friends into tertiles, a negative association was found between the number of close friends and depressive symptoms. After adjustment, the group with a higher number of close friends exhibited a 48% lower risk of depressive symptoms. An approximately L-shaped relationship was observed (nonlinear P = 0.001). Depressive symptoms decreased with an increasing number of close friends up to 10, beyond which the association plateaued.ConclusionAn approximately L-shaped relationship exists between the number of close friends and depressive symptoms. When the number of close friends was ≤10, a higher number of close friends was associated with a lower level of depressive symptoms.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261429192"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12979870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147433434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-16DOI: 10.1177/03000605261430163
Yunliang Wang, Yujian Xia, Lin Weng, Jin Wang, Wenzi Meng, Jiahui Zhu, Xin Zhao, Xinguo Zhu
ObjectiveTo explore the potential involvement of PANoptosis-related genes in gastric cancer susceptibility through multiomics analyses.MethodsSummary-data-based Mendelian randomization was performed by integrating blood-derived methylation, gene expression, and protein quantitative trait loci data with genome-wide association study results. The findings were further evaluated in The Cancer Genome Atlas cohort, followed by protein-protein interaction analysis, drug prediction, and molecular docking.ResultsSummary-data-based Mendelian randomization and colocalization analyses identified several traits suggestively associated with gastric cancer risk. Genetically predicted higher expression of apoptosis and caspase activation inhibitor (AVEN) and hepatocyte growth factor (HGF) as well as higher HGF protein levels were associated with increased risk, whereas higher levels of protein phosphatase 2 regulatory subunit B beta (PPP2R2B) appeared to be protective. Multiomics integration suggested epigenetic regulation of HGF and PPP2R2B. The Cancer Genome Atlas analysis corroborated the dysregulation of these candidates, with high AVEN expression associated with poorer survival. Protein-protein interaction and drug prediction analyses highlighted functional networks and potential therapeutics, supported by molecular docking demonstrating strong HGF-binding affinities. However, these associations did not reach statistical significance in the independent validation cohort, possibly due to limited statistical power.ConclusionsThis study identified AVEN, HGF, and PPP2R2B as potential candidate genes for gastric cancer. These findings require further validation in larger cohorts.
目的通过多组学分析,探讨panoptosis相关基因在胃癌易感性中的潜在作用。方法将血源性甲基化、基因表达和蛋白质数量性状位点数据与全基因组关联研究结果相结合,进行基于汇总数据的孟德尔随机化。研究结果在The Cancer Genome Atlas队列中进一步评估,随后进行蛋白-蛋白相互作用分析、药物预测和分子对接。结果基于汇总数据的孟德尔随机化和共定位分析确定了与胃癌风险相关的几个特征。基因预测较高的凋亡和半胱天蛋白酶激活抑制剂(AVEN)、肝细胞生长因子(HGF)以及较高的HGF蛋白水平表达与风险增加相关,而较高水平的蛋白磷酸酶2调节亚基B β (PPP2R2B)似乎具有保护作用。多组学整合提示HGF和PPP2R2B具有表观遗传调控作用。癌症基因组图谱分析证实了这些候选基因的失调,AVEN的高表达与较差的生存率相关。蛋白质-蛋白质相互作用和药物预测分析强调功能网络和潜在的治疗方法,分子对接显示出强大的hgf结合亲和力。然而,这些关联在独立验证队列中没有达到统计学意义,可能是由于统计能力有限。结论本研究确定了AVEN、HGF和PPP2R2B是胃癌的潜在候选基因。这些发现需要在更大的队列中进一步验证。
{"title":"A multiomics Mendelian randomization study on PANoptosis-related genes and gastric cancer risk.","authors":"Yunliang Wang, Yujian Xia, Lin Weng, Jin Wang, Wenzi Meng, Jiahui Zhu, Xin Zhao, Xinguo Zhu","doi":"10.1177/03000605261430163","DOIUrl":"https://doi.org/10.1177/03000605261430163","url":null,"abstract":"<p><p>ObjectiveTo explore the potential involvement of PANoptosis-related genes in gastric cancer susceptibility through multiomics analyses.MethodsSummary-data-based Mendelian randomization was performed by integrating blood-derived methylation, gene expression, and protein quantitative trait loci data with genome-wide association study results. The findings were further evaluated in The Cancer Genome Atlas cohort, followed by protein-protein interaction analysis, drug prediction, and molecular docking.ResultsSummary-data-based Mendelian randomization and colocalization analyses identified several traits suggestively associated with gastric cancer risk. Genetically predicted higher expression of apoptosis and caspase activation inhibitor (<i>AVEN</i>) and hepatocyte growth factor (<i>HGF</i>) as well as higher HGF protein levels were associated with increased risk, whereas higher levels of protein phosphatase 2 regulatory subunit B beta (PPP2R2B) appeared to be protective. Multiomics integration suggested epigenetic regulation of <i>HGF</i> and <i>PPP2R2B</i>. The Cancer Genome Atlas analysis corroborated the dysregulation of these candidates, with high <i>AVEN</i> expression associated with poorer survival. Protein-protein interaction and drug prediction analyses highlighted functional networks and potential therapeutics, supported by molecular docking demonstrating strong HGF<i>-</i>binding affinities. However, these associations did not reach statistical significance in the independent validation cohort, possibly due to limited statistical power.ConclusionsThis study identified <i>AVEN</i>, <i>HGF</i>, and <i>PPP2R2B</i> as potential candidate genes for gastric cancer. These findings require further validation in larger cohorts.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261430163"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveIn the pathogenesis of the post-injury period following nonpenetrating traumatic brain injuries (TBIs; post-TBIs), pathological metabolic changes in the oxidative status are important, as a complete understanding of their interactions can explain the concept of how oxidative metabolic-related differences develop, thereby supporting effective treatment.MethodsThis case-control study included 63 patients (mean age ± SD, 36.19 ± 11.4 years) in the post-TBI group and 32 healthy controls. Participants were tested for creatine kinase, adenosine triphosphate, and adenosine diphosphate levels using enzyme-linked immunosorbent assays and for pyruvate and lactate levels using a spectrophotometric method according to standard manufacturer protocols.ResultsThis study found abnormally decreased adenosine triphosphate and adenosine diphosphate levels in the general nonpenetrating post-TBI group versus controls. The median total adenosine triphosphate levels were 600.4 ± 46.96 in the general clinical group and 745.7 ± 49.83 mkmol/L in controls (p < 0.0001, t = 13.69, 95% confidence interval: 124.0 to 166.5). The median total adenosine diphosphate levels were 247.6 ± 33.09 in the general clinical group and 273.9 ±31.98 mkmol/L in controls (p = 0.0004, t = 3.734, 95% confidence interval: 12.20 to 40.26). Compared with controls, elevated creatine kinase levels were found in the general clinical group (p < 0.0001, t = 7.030, 95% confidence interval: -39.78 to -22.19). The median total creatine kinase (mean ± SD) levels were 129.6 ± 21.37 in the general clinical group and 98.61 ± 19.74 IU/L in controls. Higher creatine kinase (p < 0.0001, t = 4.779, 95% confidence interval: 13.16 to 32.23) and lower adenosine triphosphate levels (p < 0.001, t = 4.997, 95% confidence interval: -70.74 to -30.31) were found to be more pronounced after brain contusion compared with those following mild TBIs.ConclusionsNonpenetrating post-TBIs showed higher creatine kinase levels associated with lower adenosine triphosphate-adenosine diphosphate levels, indicating oxidative dyshomeostasis at 12-month post-injury follow-ups, which could play a pathogenetic role in post-TBIs progression.
{"title":"The impact of and changes in the oxidative status in the post-injury period following nonpenetrating traumatic brain injuries.","authors":"Yevgeniya Lekomtseva, Andrey Belousov, Tkachenko Vitaliy","doi":"10.1177/03000605261426167","DOIUrl":"10.1177/03000605261426167","url":null,"abstract":"<p><p>ObjectiveIn the pathogenesis of the post-injury period following nonpenetrating traumatic brain injuries (TBIs; post-TBIs), pathological metabolic changes in the oxidative status are important, as a complete understanding of their interactions can explain the concept of how oxidative metabolic-related differences develop, thereby supporting effective treatment.MethodsThis case-control study included 63 patients (mean age ± SD, 36.19 ± 11.4 years) in the post-TBI group and 32 healthy controls. Participants were tested for creatine kinase, adenosine triphosphate, and adenosine diphosphate levels using enzyme-linked immunosorbent assays and for pyruvate and lactate levels using a spectrophotometric method according to standard manufacturer protocols.ResultsThis study found abnormally decreased adenosine triphosphate and adenosine diphosphate levels in the general nonpenetrating post-TBI group versus controls. The median total adenosine triphosphate levels were 600.4 ± 46.96 in the general clinical group and 745.7 ± 49.83 mkmol/L in controls (p < 0.0001, t = 13.69, 95% confidence interval: 124.0 to 166.5). The median total adenosine diphosphate levels were 247.6 ± 33.09 in the general clinical group and 273.9 ±31.98 mkmol/L in controls (p = 0.0004, t = 3.734, 95% confidence interval: 12.20 to 40.26). Compared with controls, elevated creatine kinase levels were found in the general clinical group (p < 0.0001, t = 7.030, 95% confidence interval: -39.78 to -22.19). The median total creatine kinase (mean ± SD) levels were 129.6 ± 21.37 in the general clinical group and 98.61 ± 19.74 IU/L in controls. Higher creatine kinase (p < 0.0001, t = 4.779, 95% confidence interval: 13.16 to 32.23) and lower adenosine triphosphate levels (p < 0.001, t = 4.997, 95% confidence interval: -70.74 to -30.31) were found to be more pronounced after brain contusion compared with those following mild TBIs.ConclusionsNonpenetrating post-TBIs showed higher creatine kinase levels associated with lower adenosine triphosphate-adenosine diphosphate levels, indicating oxidative dyshomeostasis at 12-month post-injury follow-ups, which could play a pathogenetic role in post-TBIs progression.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261426167"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12961119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147355273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-04DOI: 10.1177/03000605261426190
Hexin Zhang, Jinxi Hu
ObjectiveTo compare the radiological and functional outcomes of the newly proposed lateral articular line approach with those of the traditional extended anterolateral approach in the management of Schatzker type II-III tibial plateau fractures involving the posterolateral quadrant.MethodsThis single-center retrospective cohort study included 90 patients who underwent open reduction and internal fixation using either lateral articular line approach (n = 45) or extended anterolateral approach (n = 45). Perioperative data (operative time, blood loss, and incision length), radiological outcomes (articular depression and posterior tibial slope), and functional recovery (Rasmussen knee scores and range of motion) were evaluated up to 12 months postoperatively.ResultsCompared with the extended anterolateral approach, the lateral articular line approach significantly reduced operative time (72.47 vs. 87.73 min, p < 0.001), blood loss (80.11 vs. 133.33 mL, p < 0.001), and incision length (6.0 vs. 15.0 cm, p < 0.001). The lateral articular line approach also achieved better reduction quality with smaller final articular depression (0.55 vs. 1.55 mm, p < 0.001) and yielded higher Rasmussen knee scores and greater range of motion at all follow-up assessments (all p < 0.05). Complication rates were comparable between the two groups.ConclusionThe lateral articular line approach offers a minimally invasive and reliable alternative to the extended anterolateral approach for Schatzker type II-III tibial plateau fractures with posterolateral involvement, providing superior reduction quality, faster recovery, and less surgical trauma.
目的比较新提出的外侧关节线入路与传统的扩展前外侧入路治疗Schatzker II-III型胫骨平台骨折后外侧象限的放射学和功能结果。方法本单中心回顾性队列研究纳入90例采用外侧关节线入路(n = 45)或扩展前外侧入路(n = 45)行切开复位内固定的患者。围手术期数据(手术时间、出血量和切口长度)、放射学结果(关节凹陷和胫骨后斜度)和功能恢复(Rasmussen膝关节评分和活动范围)在术后12个月进行评估。结果与延长前外侧入路相比,外侧关节线入路手术时间明显缩短(72.47 min vs. 87.73 min, p
{"title":"Lateral articular line versus extended anterolateral approach for Schatzker type II-III tibial plateau fractures.","authors":"Hexin Zhang, Jinxi Hu","doi":"10.1177/03000605261426190","DOIUrl":"10.1177/03000605261426190","url":null,"abstract":"<p><p>ObjectiveTo compare the radiological and functional outcomes of the newly proposed lateral articular line approach with those of the traditional extended anterolateral approach in the management of Schatzker type II-III tibial plateau fractures involving the posterolateral quadrant.MethodsThis single-center retrospective cohort study included 90 patients who underwent open reduction and internal fixation using either lateral articular line approach (n = 45) or extended anterolateral approach (n = 45). Perioperative data (operative time, blood loss, and incision length), radiological outcomes (articular depression and posterior tibial slope), and functional recovery (Rasmussen knee scores and range of motion) were evaluated up to 12 months postoperatively.ResultsCompared with the extended anterolateral approach, the lateral articular line approach significantly reduced operative time (72.47 vs. 87.73 min, p < 0.001), blood loss (80.11 vs. 133.33 mL, p < 0.001), and incision length (6.0 vs. 15.0 cm, p < 0.001). The lateral articular line approach also achieved better reduction quality with smaller final articular depression (0.55 vs. 1.55 mm, p < 0.001) and yielded higher Rasmussen knee scores and greater range of motion at all follow-up assessments (all p < 0.05). Complication rates were comparable between the two groups.ConclusionThe lateral articular line approach offers a minimally invasive and reliable alternative to the extended anterolateral approach for Schatzker type II-III tibial plateau fractures with posterolateral involvement, providing superior reduction quality, faster recovery, and less surgical trauma.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261426190"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12961140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147355234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-16DOI: 10.1177/03000605261429289
Ziad W Elmezayen, Taha AlBaik, Ezat Anini, Rafif Abu Hijleh, Nasim Abukaresh
A man in his early 50 s presented with a 7-day history of progressive, symmetrical weakness that began in the lower limbs and ascended to involve the upper limbs. His symptoms were accompanied by distal paresthesia and complete areflexia. Three weeks prior to presentation, he experienced a self-limiting febrile illness associated with dark urine and elevated transaminase levels, which resolved spontaneously. On admission, laboratory investigations demonstrated elevated liver enzyme levels and positive anti-hepatitis E virus Immunoglobulin M antibodies, confirming acute hepatitis E virus infection. Nerve conduction studies were consistent with the acute inflammatory demyelinating polyneuropathy variant of Guillain-Barré syndrome. The patient was treated with intravenous immunoglobulin (0.4 g/kg/day for 5 days) and was closely monitored for respiratory and autonomic complications. Gradual neurological improvement was observed, along with normalization of liver function tests. To the best our knowledge, this case represents the first documented occurrence of hepatitis E virus-associated Guillain-Barré syndrome in Egypt after a careful review of the literature. It underscores the importance of considering hepatitis E virus infection in the differential diagnosis of Guillain-Barré syndrome, particularly in patients presenting with elevated liver enzymes or a recent history of hepatitis in hepatitis E virus-endemic regions. Early recognition and prompt initiation of immunotherapy may improve neurological recovery and clinical outcomes in this rare but clinically significant association.
{"title":"Guillain-Barré syndrome triggered by acute hepatitis E virus infection: The first reported case from Egypt.","authors":"Ziad W Elmezayen, Taha AlBaik, Ezat Anini, Rafif Abu Hijleh, Nasim Abukaresh","doi":"10.1177/03000605261429289","DOIUrl":"https://doi.org/10.1177/03000605261429289","url":null,"abstract":"<p><p>A man in his early 50 s presented with a 7-day history of progressive, symmetrical weakness that began in the lower limbs and ascended to involve the upper limbs. His symptoms were accompanied by distal paresthesia and complete areflexia. Three weeks prior to presentation, he experienced a self-limiting febrile illness associated with dark urine and elevated transaminase levels, which resolved spontaneously. On admission, laboratory investigations demonstrated elevated liver enzyme levels and positive anti-hepatitis E virus Immunoglobulin M antibodies, confirming acute hepatitis E virus infection. Nerve conduction studies were consistent with the acute inflammatory demyelinating polyneuropathy variant of Guillain-Barré syndrome. The patient was treated with intravenous immunoglobulin (0.4 g/kg/day for 5 days) and was closely monitored for respiratory and autonomic complications. Gradual neurological improvement was observed, along with normalization of liver function tests. To the best our knowledge, this case represents the first documented occurrence of hepatitis E virus-associated Guillain-Barré syndrome in Egypt after a careful review of the literature. It underscores the importance of considering hepatitis E virus infection in the differential diagnosis of Guillain-Barré syndrome, particularly in patients presenting with elevated liver enzymes or a recent history of hepatitis in hepatitis E virus-endemic regions. Early recognition and prompt initiation of immunotherapy may improve neurological recovery and clinical outcomes in this rare but clinically significant association.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261429289"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-19DOI: 10.1177/03000605261430142
Hakan Polat, Mithat Ekşi, Alican Çatık, Azad Akdağ, Yusuf Arıkan, Ubeyd Sungur, Taner Kargı, Serdar Karadağ, Alper Bitkin
ObjectiveThis study aimed to evaluate the clinical outcomes and safety of combined duloxetine and tolterodine therapy in patients with mixed urinary incontinence.MethodsA retrospective analysis was conducted on patients with mixed urinary incontinence treated between January 2021 and December 2023. Patients received tolterodine (4 mg/day) and duloxetine (40 mg twice daily). Clinical outcomes were assessed at weeks 4 and 12 using the Overactive Bladder Symptom Score, International Consultation on Incontinence Questionnaire-Short Form, pad tests, and bladder diaries. Patient satisfaction was evaluated using the Clinical Global Impression scale.ResultsThe study included 115 patients (mean age: 46.6 ± 13.4 years). Significant improvements were observed in Overactive Bladder Symptom Score, International Consultation on Incontinence Questionnaire-Short Form scores, and pad weights at weeks 4 and 12 compared to baseline (p < 0.001). Daily micturition, nocturia, urgency, and incontinence episodes significantly decreased, whereas mean voided volume increased. According to Clinical Global Impression scores, 73.9% of patients reported partial or complete improvement. Treatment-related adverse events were observed in 12.1% of patients.ConclusionThe combination therapy of duloxetine and tolterodine appears to be safe and potentially beneficial, reducing symptom scores and incontinence episodes. However, these findings need to be supported by controlled studies.
{"title":"Clinical outcomes and safety of duloxetine and tolterodine combination in the treatment of mixed-type urinary incontinence: A single-arm retrospective study.","authors":"Hakan Polat, Mithat Ekşi, Alican Çatık, Azad Akdağ, Yusuf Arıkan, Ubeyd Sungur, Taner Kargı, Serdar Karadağ, Alper Bitkin","doi":"10.1177/03000605261430142","DOIUrl":"https://doi.org/10.1177/03000605261430142","url":null,"abstract":"<p><p>ObjectiveThis study aimed to evaluate the clinical outcomes and safety of combined duloxetine and tolterodine therapy in patients with mixed urinary incontinence.MethodsA retrospective analysis was conducted on patients with mixed urinary incontinence treated between January 2021 and December 2023. Patients received tolterodine (4 mg/day) and duloxetine (40 mg twice daily). Clinical outcomes were assessed at weeks 4 and 12 using the Overactive Bladder Symptom Score, International Consultation on Incontinence Questionnaire-Short Form, pad tests, and bladder diaries. Patient satisfaction was evaluated using the Clinical Global Impression scale.ResultsThe study included 115 patients (mean age: 46.6 ± 13.4 years). Significant improvements were observed in Overactive Bladder Symptom Score, International Consultation on Incontinence Questionnaire-Short Form scores, and pad weights at weeks 4 and 12 compared to baseline (p < 0.001). Daily micturition, nocturia, urgency, and incontinence episodes significantly decreased, whereas mean voided volume increased. According to Clinical Global Impression scores, 73.9% of patients reported partial or complete improvement. Treatment-related adverse events were observed in 12.1% of patients.ConclusionThe combination therapy of duloxetine and tolterodine appears to be safe and potentially beneficial, reducing symptom scores and incontinence episodes. However, these findings need to be supported by controlled studies.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261430142"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147480759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-03-23DOI: 10.1177/03000605261431462
Mengyuan Li, Junsu Pan, Jianhua Luo, Cheng Zheng
Furazolidone is a nitrofuran antibiotic commonly used in the treatment of Helicobacter pylori infection. Although gastrointestinal symptoms are well-documented adverse effects, furazolidone-associated drug-induced interstitial lung disease is extremely rare. Herein, we report a case of a 54-year-old Chinese woman who developed fever, dry cough, and dyspnea on day 4 of furazolidone-containing quadruple therapy. Chest computed tomography revealed diffuse bilateral interlobular septal thickening and small pleural effusions. An extensive workup excluded other causes. The Naranjo adverse drug reaction probability scale score was 6, indicating a probable association with furazolidone. Discontinuation of the drug and initiation of glucocorticoid therapy resulted in rapid clinical and radiological improvement. This case highlights that furazolidone can cause drug-induced interstitial lung disease and that early recognition and intervention are crucial for a favorable outcome.
{"title":"Furazolidone-associated drug-induced interstitial lung disease: A case report and literature review.","authors":"Mengyuan Li, Junsu Pan, Jianhua Luo, Cheng Zheng","doi":"10.1177/03000605261431462","DOIUrl":"https://doi.org/10.1177/03000605261431462","url":null,"abstract":"<p><p>Furazolidone is a nitrofuran antibiotic commonly used in the treatment of <i>Helicobacter pylori</i> infection. Although gastrointestinal symptoms are well-documented adverse effects, furazolidone-associated drug-induced interstitial lung disease is extremely rare. Herein, we report a case of a 54-year-old Chinese woman who developed fever, dry cough, and dyspnea on day 4 of furazolidone-containing quadruple therapy. Chest computed tomography revealed diffuse bilateral interlobular septal thickening and small pleural effusions. An extensive workup excluded other causes. The Naranjo adverse drug reaction probability scale score was 6, indicating a probable association with furazolidone. Discontinuation of the drug and initiation of glucocorticoid therapy resulted in rapid clinical and radiological improvement. This case highlights that furazolidone can cause drug-induced interstitial lung disease and that early recognition and intervention are crucial for a favorable outcome.</p>","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"54 3","pages":"3000605261431462"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147504009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}